Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Dermatology
•
Systemic autoimmune diseases
If methotrexate is contraindicated or not tolerated, what systemic treatments do you use for generalized morphea?
Related Questions
What is the most appropriate next step in management for a patient with dermatomyositis who is maintained on methotrexate 25 mg weekly but develops disease flare when prednisone is tapered below 10 mg daily and is unable to receive IVIG?
How do you optimize retinopathy screening schedules for patients on hydroxychloroquine while also prioritizing cost-effectiveness?
How do you clinically and diagnostically distinguish stiff skin syndrome from scleroderma?
Which serologic tests are most helpful when evaluating for suspected drug-induced lupus?
How often do you draw screening ANAs for discoid lupus?
Do you always biopsy patients who present with classic skin findings of dermatomyositis?
How do you counsel patients with dermatomyositis on sun protection?
Do you check IgA levels before starting IVIG for other autoimmune conditions?
What clinical features help distinguish classical or vascular EDS from hypermobile EDS in patients presenting with joint hypermobility?
How do you approach patients who identify so strongly with being sick or with a particular diagnostic label that it makes up a significant portion of their identity?
